Results 21 to 30 of about 52 (31)
Cerebrolizyna — ocena skuteczności i bezpieczeństwa w leczeniu otępienia alzheimerowskiego i naczyniowego [PDF]
Leczenie otępienia w chorobie Alzheimera (AD, Alzheimer’s disease), a także otępienia naczyniowego (VaD, vascular dementia), od lat pozostaje niezmienne.
Sławek, Jarosław; Oddział Neurologii Szpital św. Wojciecha Podmiot Leczniczy Copernicus sp. z o.o. w Gdańsku, Al. Jana Pawła II 50, 80–462 Gdańsk, Poland
core
Substances of plant origin and their potential application in treating Alzheimer’s disease [PDF]
Alzheimer’s disease is the most common neurodegenerative condition in elderly people which is characterised by progressing dementia. Patients present weaker episodic memory, attention and orientation disorders as well as cognitive and language ...
Pypno, Damian, Zdrojewicz, Zygmunt
core
Pharmacotherapy of cognitive dysfunctions in Alzheimer’s disease: current strategies and experimental therapies [PDF]
Currently available methods of pharmacological treatment of cognitive dysfunction related to Alzheimer’s disease (AD) are based on augmentation of cholinergic neurotransmission (by inhibiting activity of cholinesterases) or modulation of glutamatergic ...
Sobów, Tomasz
core
Active and passive immunization strategies as treatments of Alzheimer’s disease [PDF]
Currently available pharmacotherapeutics (cholinesterase inhibitors and memantin) for Alzheimer’s disease (AD) exert mainly symptomatic effect and doubtful, if any, disease-modifying activities.
Sobów, Tomasz
core
Memantyna - strategia glutaminergiczna w leczeniu choroby Alzheimera
openaire
Memantyna i inhibitory chlinesteraz: terapia skojarzona choroby Alzheimera
openaire
Katatonia jest niedostatecznie rozpoznawana i diagnozowana — do jej rozpoznania wystarczą jedynie dwa objawy w Skali Oceny Katatonii Busha-Francisa. Benzodiazepiny, zwłaszcza lorazepam i diazepam, stanowią leczenie pierwszego wyboru.
S. Beach
semanticscholar +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Inhibitory cholinesterazy i memantyna: racjonalne wybory czy intuicja?
Neuropsychiatria. Przegląd Kliniczny, 2013openaire

